Illumina and Vertex - Monopoly's the Game | The Mad Hedge Fund Trader

I am pleased to announce the launch of the Mad Hedge Biotech & Healthcare Trade Alert Service.

The goal is to alert traders and investors when entry sweet spots occur for Biotech & Healthcare stocks with the strongest long-term fundamentals.

Don’t expect any immediate trade alerts today, tomorrow, this week, or even this month. Actual market sweet spots are rare and only take place after prolonged bottoming processes. However, they DO make it easier for investors to move into the best companies at the right time and achieve immediate profits.

Each alert will include recommendations for the stock, options, and ETF so you can tailor the position to your own level of experience and risk tolerance.

In order to receive Biotech text alerts, we need your cell phone number to get text messages to you immediately. To register, please click here.

I look forward to working with you with this service.

John Thomas
CEO & Publisher
The Mad Hedge Biotech & Healthcare Letter

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.